Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

- PMLiVE

Fair to medalling

Generally competent at strategic planning, how can pharma transition from acceptable to exceptional to deliver gold standard performances?

- PMLiVE

Strengthening market access deliverables by harnessing the patient journey

In today’s multi-stakeholder environment, pharma companies need to coordinate their stakeholder interactions between functions to ensure consistency of message and efficiency of cost. Market access has a critical role to...

- PMLiVE

Novimmune expands senior management team

Dr Sven Zimmerman and Mylène Fleurant join the Swiss biotech

- PMLiVE

McCann Health creates new global consultancy

Former Novartis exec Simon Holt to head up Consulting at McCann Health

Sanofi reception

Sanofi eyes March approval for dupilumab in atopic dermatitis

Analysts suggest sales could reach $2.8bn annually if licensed in eczema and asthma

- PMLiVE

Amgen claims first US go-ahead for Humira biosimilar

Amjevita receives FDA approval but faces patent infringement lawsuit from AbbVie

- PMLiVE

Choosing destiny

As our market transforms, firms must choose their new business model carefully

- PMLiVE

Durbin appoints US business development principal

Todd Galles now takes up the role on a permanent basis

- PMLiVE

Lanthio Pharma bolsters management team

Dr Axel Mescheder appointed CMO of MorphoSys subsidiary

- PMLiVE

Chiesi’s Holoclar wins UK Prix Galien orphan drug award

Novartis and Astellas also scoop prizes at the prestigious ceremony

- PMLiVE

Virgo Health launches healthcare innovation hub

The Egg service specialises in creating holistic solutions for patients and HCPs

- PMLiVE

Consilium Strategic Communications wins Vectura account

Will advise on financial and corporate PR following SkyePharma merger

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links